Similar articles

• Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.

  Shimizu Y, Kato H, Schull WJ, Preston DL, Fujita S, Pierce DA. Shimizu Y, et al. Radiat Res. 1989 Jun;118(3):502-24. Radiat Res. 1989. PMID: 2727272
• Experimental derivation of relative biological effectiveness of A-bomb neutrons in Hiroshima and Nagasaki and implications for risk assessment.

  Sasaki MS, Nomura T, Ejima Y, Utsumi H, Endo S, Saito I, Itoh T, Hoshi M. Sasaki MS, et al. Radiat Res. 2008 Jul;170(1):101-17. doi: 10.1667/RR1249.1. Radiat Res. 2008. PMID: 18582156
• Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971.

  Ishimaru T, Otake M, Ischimaru M. Ishimaru T, et al. Radiat Res. 1979 Feb;77(2):377-94. Radiat Res. 1979. PMID: 286375 No abstract available.
• Neutron relative biological effectiveness in Hiroshima and Nagasaki atomic bomb survivors: a critical review.

  Sasaki MS, Endo S, Hoshi M, Nomura T. Sasaki MS, et al. J Radiat Res. 2016 Nov;57(6):583-595. doi: 10.1093/jrr/rrw079. Epub 2016 Sep 10. J Radiat Res. 2016. PMID: 27614201 Free PMC article. Review.
• [Evaluation of cancer risk by ionizing radiation after dosimetry revision of Hiroshima and Nagasaki].

  Breckow J. Breckow J. Med Klin (Munich). 1991 Feb 15;86(2):92-8. Med Klin (Munich). 1991. PMID: 2030666 Review. German. No abstract available.